Hyperliquid Token Defies Market Trends Amid Institutional Moves
- Sonnet BioTherapeutics is merging with Rorschach I LLC to form Hyperliquid Strategies Inc., valued at $888 million.
- The decentralized exchange Hyperliquid’s HYPE token rose nearly 7% in the last day, contrasting with the broader market trend.
- A new digital asset treasury will include about $583 million in HYPE tokens, with a $1 billion facility for potential purchases.
- Competitor BNB Chain’s Aster token fell by approximately 7.6% over the same period.
The merger of Sonnet BioTherapeutics and Rorschach I LLC into Hyperliquid Strategies Inc. marks a significant institutional investment into the Hyperliquid ecosystem, boosting confidence in its HYPE token despite broader market declines.
This strategic move positions HYPE favorably against competitors like Aster, which has seen a decline amid shifting market narratives and profit-taking behaviors. Source
